国际简称:J CARDIOVASC ECHOGR 参考译名:心血管超声检查杂志
主要研究方向:CARDIAC & CARDIOVASCULAR SYSTEMS 非预警期刊 审稿周期:
《心血管超声检查杂志》(Journal Of Cardiovascular Echography)是一本由Wolters Kluwer Health出版的以CARDIAC & CARDIOVASCULAR SYSTEMS为研究特色的国际期刊,发表该领域相关的原创研究文章、评论文章和综述文章,及时报道该领域相关理论、实践和应用学科的最新发现,旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊,近三年没有被列入预警名单。
The Journal of Cardiovascular Echography is an academic journal dedicated to the field of cardiovascular ultrasound. Intended to disseminate research results, clinical application experience, and the latest developments in related fields of cardiovascular ultrasound technology. It provides an important communication platform for cardiovascular ultrasound professionals, cardiologists, researchers, and others.
Readers can obtain specific content and more information about the magazine through relevant databases or its official website. It is of great significance in promoting research in the field of cardiovascular ultrasound, improving clinical diagnostic level, and advancing the further development of this technology. The content published covers various topics related to cardiovascular ultrasound, including but not limited to new advances in echocardiography technology, evaluation of cardiac structure and function, ultrasound diagnosis of cardiovascular diseases, research on heart valve diseases, ultrasound manifestations of myocardial diseases, etc. By publishing high-quality original research papers, review articles, case reports, etc., the academic development and clinical practice of cardiovascular ultrasound have been promoted.
| CiteScore | SJR | SNIP | CiteScore 指数 | ||||||||||||
| 1.4 | 0.249 | 0.291 |
|
名词解释:CiteScore 是衡量期刊所发表文献的平均受引用次数,是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年(含计算年度)的被引次数除以该期刊近四年发表的文献数。例如,2022年的 CiteScore 计算方法为:2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量 注:文献类型包括:文章、评论、会议论文、书籍章节和数据论文。
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
| 学科:CARDIAC & CARDIOVASCULAR SYSTEMS | ESCI | Q4 | 187 / 220 |
15.2% |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
| 学科:CARDIAC & CARDIOVASCULAR SYSTEMS | ESCI | Q4 | 189 / 220 |
14.32% |